Francesca Caparrotti
Postoperative radiotherapy for meningiomas - a decision-making analysis.
Fischer G, Brügge D, Andratschke N, Baumert B, Bosetti D, Caparrotti F, Herrmann E, Papachristofilou A, Rogers S, Schwyzer L, Zwahlen D, Hundsberger T, Putora P. Postoperative radiotherapy for meningiomas - a decision-making analysis. BMC cancer 2022; 22:492.
May 4, 2022Postoperative radiotherapy for meningiomas - a decision-making analysis.
May 4, 2022BMC cancer 2022; 22:492
Fischer Galina Farina, Brügge Detlef, Andratschke Nicolaus, Baumert Brigitta Gertrud, Bosetti Davide Giovanni, Caparrotti Francesca, Herrmann Evelyn, Papachristofilou Alexandros, Rogers Susanne, Schwyzer Lucia, Zwahlen Daniel Rudolf, Hundsberger Thomas, Putora Paul Martin
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Glatzer M, Kocher G, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Kestenholz P, Karenovics W, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Putora P. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
Apr 1, 2021Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Apr 1, 2021Transl Lung Cancer Res 2021; 10:1960-1968
Glatzer Markus, Kocher Gregor Jan, Kraxner Peter, Krueger Thorsten, Martucci Francesco, Oehler Christoph, Ozsahin Mahmut, Papachristofilou Alexandros, Wagnetz Dirk, Zaugg Kathrin, Zwahlen Daniel, Opitz Isabelle, Kestenholz Peter, Karenovics Wolfram, Leskow Pawel, Caparrotti Francesca, Elicin Olgun, Furrer Markus, Gambazzi Franco, Dutly André, Gelpke Hans, Guckenberger Matthias, Heuberger Jürg, Inderbitzi Rolf, Cafarotti Stefano, Putora Paul Martin
MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Wirsching H, Tabatabai G, Ochsenbein A, Roth P, Remonda L, Conen K, Caparrotti F, von Moos R, Hottinger A, Hundsberger T, Weller J, Roelcke U, Weller M. MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clin Cancer Res 2020; 27:179-188.
Sep 23, 2020MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Sep 23, 2020Clin Cancer Res 2020; 27:179-188
Wirsching Hans-Georg, Tabatabai Ghazaleh, Ochsenbein Adrian, Roth Patrick, Remonda Luca, Conen Katrin, Caparrotti Francesca, von Moos Roger, Hottinger Andreas F, Hundsberger Thomas, Weller Jonathan, Roelcke Ulrich, Weller Michael
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Elicin O, Giger R, Spielmann T, Prestwich R, Riesterer O, Kaydıhan N, Shelan M, Guckenberger M, Ozsahin M, Anschuetz L, Adam L, Henke G, Studer G, Zimmermann F, Caparrotti F, Aebersold D, Oehler C, Ermiş E, Şen M. Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study. Front Oncol 2019; 9:932.
Sep 20, 2019Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Sep 20, 2019Front Oncol 2019; 9:932
Elicin Olgun, Giger Roland, Spielmann Thierry, Prestwich Robin J D, Riesterer Oliver, Kaydıhan Nuri, Shelan Mohamed, Guckenberger Matthias, Ozsahin Mahmut, Anschuetz Lukas, Adam Lukas, Henke Guido, Studer Gabriela, Zimmermann Frank, Caparrotti Francesca, Aebersold Daniel M, Oehler Christoph, Ermiş Ekin, Şen Mehmet